Calidad de la evidencia 4.63/5
Puntuación de revisión en ocho dimensiones según la rúbrica de calidad . Cada dimensión puntuada de 1 a 5.
- D1 Anclaje en las fuentes
- 4/5
- D2 Autoridad de las fuentes
- 5/5
- D3 Aritmética
- 5/5
- D4 Incertidumbre
- 4/5
- D5 Alcance
- 5/5
- D6 Prosa
- 5/5
- D7 Honestidad sobre la percepción
- 4/5
- D8 Completitud de las advertencias
- 5/5
Cómo varía el riesgo
La cifra principal promedia situaciones muy diferentes. Así es como varía la probabilidad según el escenario o el contexto:
1 de cada 1.000.000
Structural floor. Ambient RF power density from cell towers at ground level is typically 1,000-10,000x below ICNIRP general public limits. No epidemiological study has found elevated cancer incidence in populations living near base stations. Multiple ecological studies (UK, Germany, Israel) have looked; none found a signal after controlling for confounders.
1 de cada 200.000
Placeholder reflecting the INTERPHONE top-decile finding (OR 1.40 for glioma) which the study authors attributed to bias. If the association were causal, the absolute risk increase over a baseline lifetime glioma rate of ~0.6% would be small. The FDA and WHO do not consider this finding sufficient to establish causation.
1 de cada 333.333
Telecom workers installing and maintaining antennas can experience near-field exposures closer to ICNIRP occupational limits. Occupational studies have not found consistent cancer elevation, but sample sizes are small. ICNIRP occupational limits are set with a 50x reduction factor below thermal thresholds.
1 de cada 1.000.000
mmWave radiation is absorbed in the outer layers of skin and does not penetrate to internal organs. ICNIRP 2020 guidelines explicitly cover these frequencies. No epidemiological data exists for mmWave-specific cancer risk because population-scale exposure only began in 2020. The physics of shallow penetration depth makes internal organ effects implausible at guideline-compliant levels.
La longitud y el tono de la barra clasifican estos escenarios entre sí, no frente a otros riesgos. Las probabilidades exactas se muestran junto a cada uno.
La base de evidencia para los campos electromagnéticos de radiofrecuencia (RF-EMF) y el cáncer está inusualmente polarizada entre los organismos reguladores. La IARC clasificó los campos electromagnéticos de radiofrecuencia como Grupo 2B (“posiblemente carcinogénicos”) en 2011, basándose principalmente en el hallazgo del estudio INTERPHONE de un riesgo elevado de glioma del 40% en el decil más alto de uso acumulado del teléfono, un resultado que los propios autores del estudio dijeron que no podía interpretarse causalmente debido al sesgo de recuerdo y al sesgo de selección. La razón de posibilidades (odds ratio) general de INTERPHONE para el glioma fue en realidad inferior a 1.0 (OR 0.81), lo que sugiere un efecto protector que todos están de acuerdo en que es artificial. Mientras tanto, la revisión de la FDA de 2020, el WHO EMF Project, la actualización de las directrices de ICNIRP de 2020 y el 18º informe COMARE del Reino Unido concluyeron que el peso de la evidencia no respalda un vínculo causal entre la exposición a RF-EMF a niveles que cumplen con las directrices y el cáncer. Las directrices de ICNIRP de 2020 cubren explícitamente las frecuencias 5G de hasta 300 GHz y no encontraron base científica para revisar los límites de exposición de 1998, solo reestructuraron su forma para mayor claridad.
Lo que hace que el miedo al 5G sea distintivo es menos la ciencia que la sociología. El despliegue coincidió con la pandemia de COVID-19, y las teorías de conspiración que vinculaban ambos impulsaron ataques incendiarios contra docenas de torres de telefonía móvil en el Reino Unido, Irlanda y los Países Bajos a principios de 2020. La clasificación IARC 2B —diseñada como una etiqueta de identificación de peligro, no una cuantificación de riesgo— fue rutinariamente despojada de contexto y presentada como prueba de que “la OMS dice que los teléfonos móviles causan cáncer”. El Grupo 2B contiene más de 300 agentes, incluyendo extracto de hoja entera de aloe vera, vegetales encurtidos y talco; significa que existe evidencia limitada que no puede ser descartada, no que se haya establecido un riesgo. La distinción entre el marco de la IARC (que pregunta “¿podría esto causar cáncer bajo cualquier escenario de exposición?”) y la evaluación de riesgo de la OMS (que pregunta “¿causa esto cáncer a niveles del mundo real?”) es sutil y se pierde sistemáticamente en la cobertura mediática.
Para la subpregunta del teléfono en el bolsillo, la entrada sobre exposición testicular al calor en este sitio cubre la vía de evidencia más sólida: efectos térmicos en los parámetros del semen debido al calor del dispositivo, no la carcinogénesis específica de RF. El metaanálisis de Adams de 2014 encontró una reducción de la motilidad del 8.1% asociada con la exposición al teléfono, pero los intervalos de confianza son amplios, los estudios incluidos mezclan irradiación in vitro con autoinformes observacionales, y ningún estudio midió los resultados de fertilidad. La American Cancer Society no incluye los RF-EMF entre los factores de riesgo de cáncer testicular. Para el 5G específicamente, las frecuencias de ondas milimétricas (24-39 GHz) se absorben en las capas externas de la piel y no penetran en los órganos internos —una restricción física que hace que el riesgo de cáncer interno sea inverosímil a niveles de potencia que cumplen con ICNIRP, aunque los datos epidemiológicos a escala poblacional para estas frecuencias aún no existen porque el despliegue es demasiado reciente.
Datos curiosos relacionados
Las torres 5G emiten radiacion no ionizante a niveles miles de veces por debajo de los limites de seguridad. No existe mecanismo biologico plausible de dano. La OMS, la FDA y la ICNIRP coinciden. La ansiedad es real. El riesgo no.
Registro de evidencia
Cada número a continuación es lo que reportó cada fuente, con la cita textual en la que nos basamos y cómo llegamos a nuestra cifra. Haz clic en cualquier enlace para verificarlo directamente.
1/6 fuentes verificadas de forma independiente palabra por palabra frente a la fuente citada
-
[1] International Agency for Research on Cancer (WHO/IARC) — IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans
IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans- Estadística
RF-EMF classified as Group 2B ('possibly carcinogenic to humans') based on limited evidence of glioma in heavy mobile phone users- Extracto
“"The evidence was reviewed critically, and overall evaluated as being limited2 among users of wireless telephones for glioma and acoustic neuroma, and inadequate3 to draw conclusions for other types of cancers. The evidence from the occupational and environmental exposures mentioned above was similarly judged inadequate. The Working Group did not quantitate the risk; however, one study of past cell phone use (up to the year 2004), showed a 40% increased risk for gliomas in the highest category of heavy users (reported average: 30 minutes per day over a 10-year period)." ”
- Datos de la fuente de
- 2011-05-31
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- The IARC Monograph 102 Working Group evaluated RF-EMF based primarily on the Interphone study (2010) and Hardell group case-control studies. The 40% glioma increase was observed only in the highest decile of cumulative call time in Interphone, and the Interphone authors themselves cautioned that recall bias and selection bias could account for the finding. Group 2B is IARC's second-lowest risk category — it indicates limited evidence in humans and less than sufficient evidence in animals. Over 300 agents are classified 2B, including aloe vera extract, pickled vegetables, and occupational dry cleaning. The classification does not constitute a risk quantification.
-
[2] International Commission on Non-Ionizing Radiation Protection (ICNIRP) — Guidelines for Limiting Exposure to Electromagnetic Fields (100 kHz to 300 GHz)
Guidelines for Limiting Exposure to Electromagnetic Fields (100 kHz to 300 GHz)- Estadística
ICNIRP 2020 guidelines set exposure limits with large safety factors; 5G frequencies (sub-6 GHz and mmWave up to 300 GHz) remain non-ionizing and within the same framework- Extracto
“"This document presents these revised Guidelines, which provide protection for humans from exposure to EMFs from 100 kHz to 300 GHz. … Reduction factors account for biological variability in the population (e.g., age, sex), variation in baseline conditions (e.g., tissue temperature), variation in environmental factors (e.g., air temperature, humidity, clothing), dosimetric uncertainty associated with deriving exposure values, uncertainty associated with the health science, and as a conservative measure more generally." ”
- Datos de la fuente de
- 2020-03-11
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- ICNIRP's 2020 update reviewed the entire post-1998 literature, including studies at frequencies used by 5G (sub-6 GHz and mmWave 24-300 GHz). The guidelines explicitly cover 5G frequencies. The only confirmed health effect at these frequencies is tissue heating, and the exposure limits incorporate reduction factors of 50x (occupational) to 200x (general public) below thresholds where thermal effects begin. Actual 5G small cell power output is typically lower per base station than 4G macro towers because of the densified architecture. ICNIRP is the independent scientific body whose guidelines are adopted by most national regulators outside the US (the FCC uses IEEE standards that reach similar conclusions).
-
[3] The Lancet Oncology / INTERPHONE Study Group — Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study
Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study- Estadística
No overall increased risk of glioma or meningioma with mobile phone use; OR 0.81 (95% CI 0.70-0.94) for glioma overall; elevated OR 1.40 (95% CI 1.03-1.89) only in the highest decile of cumulative call time- Extracto
“"Overall, no increase in risk of glioma or meningioma was observed with use of mobile phones. There were suggestions of an increased risk of glioma at the highest exposure levels, but biases and error prevent a causal interpretation." ”
- Datos de la fuente de
- 2010-05-17
- Accedido
- 2026-04-18
- Cálculo
- The INTERPHONE study is the largest case-control study of cell phone use and brain tumors, covering 13 countries with 2,708 glioma cases and 2,409 meningioma cases. The overall odds ratio for glioma was protective (0.81), which the authors attributed to participation bias. The elevated OR in the top decile (1.40) is the primary finding that drove the IARC 2B classification. The authors explicitly stated that "biases and error prevent a causal interpretation" of the top-decile result. The study covered phone use up to 2004 — before 4G, let alone 5G — and measured cumulative call time, not ambient tower exposure.
- Independencia
- INTERPHONE is the primary study underlying the IARC classification; the IARC source above is a downstream interpretation of this and other data. They are not independent but serve different roles — INTERPHONE provides the data, IARC provides the regulatory classification.
-
[4] US Food and Drug Administration — Scientific Evidence for Cell Phone Safety (Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer)
Scientific Evidence for Cell Phone Safety (Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer)- Estadística
FDA concluded that the weight of scientific evidence does not support the conclusion that non-ionizing RF energy from cell phones causes cancer- Extracto
“"Based on the evaluation of the currently available information, the FDA believes that the weight of the scientific evidence does not support an increase in health risks from radio frequency exposure from cell phone use at or below the radio frequency exposure limits set by the FCC." ”
- Datos de la fuente de
- 2020-02-10
- Accedido
- 2026-06-30 · copia archivada
- Cálculo
- The FDA's 2020 review covered epidemiological, animal, and in vitro studies published between 2008 and 2018. The review explicitly addressed the NTP (National Toxicology Program) rat study, which found some evidence of schwannoma in male rats exposed to whole-body RF at SAR levels 2-8x the human safety limit for 9 hours/day over 2 years. The FDA concluded that the NTP results were not generalizable to human cell phone use because of the vastly higher exposure levels and whole-body irradiation protocol. This is the US regulatory counterpart to ICNIRP; both bodies reached the same conclusion using different review processes.
- Independencia
- The FDA review is an independent US regulatory assessment. It evaluates some of the same underlying studies as IARC Monograph 102 but applies a different weight-of-evidence framework and reaches a distinct conclusion about the sufficiency of evidence for a causal link.
-
[5] World Health Organization — Electromagnetic fields and public health: mobile phones
Electromagnetic fields and public health: mobile phones- Estadística
WHO states that there is no evidence to conclude that exposure to low level electromagnetic fields is harmful to human health- Extracto
“"Despite extensive research, to date there is no evidence to conclude that exposure to low level electromagnetic fields is harmful to human health. … The user of a mobile phone encounters field levels that are much higher than any levels in the normal living environment. However, even these increased levels do not appear to generate harmful effects." ”
- Datos de la fuente de
- 2014-10-08
- Accedido
- 2026-04-18 · copia archivada
- Cálculo
- The WHO EMF Q&A page is the most widely cited public-health summary on mobile phone safety. It post-dates the IARC 2B classification and explicitly notes that the overall evidence does not suggest detrimental effects. WHO's own position — "no evidence to conclude that exposure to low level electromagnetic fields is harmful" — is more conservative than the Group 2B label, reflecting the difference between IARC's hazard identification framework (which asks "could this ever cause cancer under any conditions?") and WHO's risk assessment framework (which asks "does this cause cancer at real-world exposure levels?").
-
[6] Environment International (Adams, Galloway, Mondal, Esteves & Mathews, 2014) — Effect of mobile telephones on sperm quality: a systematic review and meta-analysis Verificado
Effect of mobile telephones on sperm quality: a systematic review and meta-analysisVer las 2 entradas de Likelier que citan esta fuente →
- Estadística
Meta-analysis of 10 studies (1,492 samples) found mobile phone exposure associated with an 8.1% reduction in sperm motility (mean difference -8.1%, 95% CI -13.1 to -3.2)- Extracto
“"Exposure to mobile phones was associated with reduced sperm motility (mean difference -8.1% (95% CI -13.1, -3.2))." ”
- Datos de la fuente de
- 2014-09-01
- Accedido
- 2026-07-03 · copia archivada
- Verificación
- Extracto recuperado de forma independiente y confirmado palabra por palabra frente a la fuente citada durante nuestra auditoría de fundamentación.
- Cálculo
- Adams et al. (2014, Environment International) pooled 10 studies covering 1,492 semen samples, mixing in vitro irradiation experiments with observational self-report studies. This is the source for the "8.1% motility reduction" figure cited in the body's phone-in-pocket aside; the wide confidence interval (-13.1 to -3.2) is why the body describes the finding as uncertain. No study in the meta-analysis measured actual fertility or conception outcomes, only semen parameters. This source is unrelated to this entry's own cancer-risk conclusion — it backs only the tangential thermal/sperm-quality mention, which is covered in full on the separate testicular-heat-exposure entry.